menu
    • menu

    Company profile for NeuroVive Pharmaceutical AB

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio also consists of projects for genetic mitochondrial disorders, cancer and NASH.The company advances drugs for rare diseases through clin...
    NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio also consists of projects for genetic mitochondrial disorders, cancer and NASH.The company advances drugs for rare diseases through clinical development into the market. For projects for common indications the goal is out-licensing in the preclinical phase.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroVive Pharmaceutical ABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    NeuroVive Pharmaceutical AB Medicon Village 223 81 Lund, Sweden
    Telephone
    Telephone
    +46 [0] 46-275 62 20
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.neurovive.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neurovive-pharmaceutical-ab-ntp-/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NeuroVive Completes Recruitment in 2nd Part of its Ongoing KL1333 Ph Ia/b Study
    NeuroVive Completes Recruitment in 2nd Part of its Ongoing KL1333 Ph Ia/b Study

    20 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurovive-completes-recruitment-in-the-second-part-of-its-ongoing-kl1333-clinical-phase-iab-study-300978348.html

    PR NEWSWIRE
    20 Dec 2019
    Share Share
    NeuroVive settles dispute with CicloMulsion regarding certain pharma technology
    NeuroVive settles dispute with CicloMulsion regarding certain pharma technology

    16 Dec 2019

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=119994&sid=2

    PHARMABIZ
    16 Dec 2019
    Share Share
    NeuroVive Receives Vinnova Funding to Support Development of NV354
    NeuroVive Receives Vinnova Funding to Support Development of NV354

    15 Nov 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurovive-receives-vinnova-funding-to-support-development-of-nv354-a-novel-treatment-for-genetic-mitochondrial-disorders-300751132.html

    PR NEWSWIRE
    15 Nov 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search